PRospectIve ObseRvatIonal mulTicenter study of patients with arterial hYpertension and CKD in the population of Russia - PRIORITY-CKD

Study identifier:D1843R00360

ClinicalTrials.gov identifier:NCT06372431

EudraCT identifier:N/A

CTIS identifier:N/A

Recruiting

Official Title

Multicenter, non-interventional observational prospective study with retrospective analysis to describe the rate of CKD diagnosis, in patients with arterial hypertension and CKD markers

Medical condition

arterial hypertension, chronic kidney disease

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Estimated Enrollment

10000

Study type

Observational

Age

18 Years - n/a

Date

Study Start Date: 27 Apr 2024
Estimated Primary Completion Date: 31 Oct 2025
Estimated Study Completion Date: 31 Oct 2025

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Sept 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria